You’ve read the miracle thread and the horror thread. A friend swears by it; a headline says it’ll wreck you. The clinic wants a card on file, the forum wants you in deeper, and a confident, machine-written “protocol” has an answer for everything — and you’re no closer to a decision.
That’s not your failure. That’s the noise doing its job. The Peptide Era is the map through it: an evidence-first guide that grades every claim about GLP-1s — semaglutide, tirzepatide, retatrutide, and what comes next — on a named Evidence Ladder, from large human trials down to a stranger’s anecdote, so you can tell what’s proven from what’s merely loud.
What’s inside
- What GLP-1 medicines actually do — and where the evidence quietly thins out.
- How to read a headline or a study without getting played.
- The real risks, and the overblown ones, told straight.
- Muscle, cravings, older age, the gray market, and what’s coming next.
- Where the honest answer is still “we don’t know” — said plainly.
How it’s different
No doses. No sourcing. No miracle cures — by design. Every claim is sourced. Every uncertainty is named out loud. There’s nothing here for sale but the book.
It’s for the overwhelmed person considering these medicines, already taking one, or watching someone they love decide. You won’t be handed an answer — you’ll walk in able to weigh one.
Questions readers ask
What is The Peptide Era about?
It’s an evidence-first guide to GLP-1 medicines — semaglutide, tirzepatide, retatrutide, and what’s coming next — and the wider science of weight and metabolic health. It grades every claim on a named Evidence Ladder, from large human trials down to a single anecdote, so you can tell what’s actually proven from what only sounds certain. It’s educational, not medical advice.
Does the book tell me what to take or how to dose it?
No — by design. There are no doses, no sourcing, and no protocols. The book explains what the science does and doesn’t show; decisions about any medicine belong between you and a licensed clinician.
What’s the difference between semaglutide and tirzepatide?
Both are injectable medicines that act on gut-hormone pathways involved in appetite and blood sugar; tirzepatide acts on a second pathway (GIP) as well. What each is approved for — and how strong the evidence is — varies by country, product, and use. The book lays out what the trials actually show for each, names who funded them, and flags where the evidence thins, current as of June 2026. General information, not a recommendation.
Does it cover retatrutide and newer drugs?
Yes. Retatrutide and other emerging agents get a full, honest hearing — graded as early-stage human evidence rather than settled fact, with their regulatory status as of June 2026 stated plainly. The book is careful never to let early results sound more certain than they are.
Is the book medically reviewed?
It was fact-checked against primary sources — peer-reviewed journals, FDA labels, and clinical-trial registries — but it has not undergone formal medical review, and it is not a substitute for advice from your own clinician. We’d rather tell you that plainly than imply a review that didn’t happen.
Was it written with AI?
Yes, transparently: the book was AI-assisted and human-edited, then fact-checked against primary sources and reviewed for accuracy and safety. The aim was to use the tools to be more thorough and more honest — every claim still had to earn its place against a real source.
What formats can I get, and where?
Right now it’s available here as a DRM-free EPUB that reads on any phone, tablet, e-reader, or computer. Wider availability across other stores and libraries is rolling out.
About the author
Jonas Samuelsson is the author of The Peptide Era. He isn’t a doctor, and the book makes no claim of medical authority — that’s rather the point. It was written as the guide he couldn’t find: one with no clinic to feed, no supplement to sell, and no stake in what you decide. The book has no commercial relationship with any drug maker, seller, or clinic. Its only job is to help you weigh the evidence for yourself, then take sharper questions to a professional who knows you.